"The U.S. Food and Drug Administration today approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.
Psoriasis is a skin condition that causes patches of skin redness and irritation. Psoriasis is"...
DOSAGE AND ADMINISTRATION
ApexiCon® E Cream (diflorasone diacetate cream USP 0.05% [emollient]) should be applied to the affected areas as a thin film from one to three times daily depending on the severity or resistant nature of the condition.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy initiated.
ApexiCon® E Cream (diflorasone diacetate cream USP 0.05% [emollient]) is available in the following size tubes:
NDC 0462-0395-30 30 gram tube
NDC 0462-0395-60 60 gram tube
Store at controlled room temperature 20° - 25°C (68° -77°F) [see USP].
PharmaDerm., A division of Nycomed US Inc.Melville, NY 11747, USA. www.pharmaderm.com. Rev: 1/08
Last reviewed on RxList: 9/21/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional ApexiCon E Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.